Follow Invezz on Telegram , Twitter , and Google News for instant updates > Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) opened more than 30% up on Monday after reporting promising results from a late-stage trial of its heart drug. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins. Shares of the biopharmaceutical company are now trading at a year-to-date high of $220. Why is it significant for Alnylam Pharmaceuticals stock? Copy link to section Vutrisiran ...